Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived stromal vascular fraction (SVF) in knee osteoarthritis
KCT0011317Phase 4Completed
- Sponsor
- DongKoo Bio & Pharma
- Start
- Jul 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of autologous adipose-derived stromal vascular fraction in knee osteoarthritis (OA) (2 arms), sponsored by DongKoo Bio & Pharma. Started Jul 2020; status: completed.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on KCT0011317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011317.